156 related articles for article (PubMed ID: 25024650)
1. Development and evaluation of a measure to assess restorative sleep.
Drake CL; Hays RD; Morlock R; Wang F; Shikiar R; Frank L; Downey R; Roth T
J Clin Sleep Med; 2014 Jul; 10(7):733-41, 741A-741E. PubMed ID: 25024650
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of the Japanese version of the Restorative Sleep Questionnaire in community samples.
Ibata R; Takano Y; Machida N; Ubara A; Motoya R; Okajima I
Sleep Med; 2023 Aug; 108():45-52. PubMed ID: 37320958
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
4. Nonrestorative sleep as a distinct component of insomnia.
Roth T; Zammit G; Lankford A; Mayleben D; Stern T; Pitman V; Clark D; Werth JL
Sleep; 2010 Apr; 33(4):449-58. PubMed ID: 20394313
[TBL] [Abstract][Full Text] [Related]
5. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
7. A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression.
Snyder E; Cai B; DeMuro C; Morrison MF; Ball W
J Clin Sleep Med; 2018 Nov; 14(11):1849-1857. PubMed ID: 30373688
[TBL] [Abstract][Full Text] [Related]
8. A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects.
Horoszok L; Baleeiro T; D'Aniello F; Gropper S; Santos B; Guglietta A; Roth T
Hum Psychopharmacol; 2014 May; 29(3):266-73. PubMed ID: 24911577
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).
Hudgens S; Phillips-Beyer A; Newton L; Seboek Kinter D; Benes H
Patient; 2021 Mar; 14(2):249-268. PubMed ID: 33131027
[TBL] [Abstract][Full Text] [Related]
10. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
Lasch K; Joish VN; Zhu Y; Rosa K; Qiu C; Crawford B
Curr Med Res Opin; 2009 Jul; 25(7):1699-710. PubMed ID: 19505198
[TBL] [Abstract][Full Text] [Related]
11. Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial.
Morin CM; Edinger JD; Krystal AD; Buysse DJ; Beaulieu-Bonneau S; Ivers H
Trials; 2016 Mar; 17(1):118. PubMed ID: 26940892
[TBL] [Abstract][Full Text] [Related]
12. Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem.
Svetnik V; Ferri R; Ray S; Ma J; Walsh JK; Snyder E; Ebert B; Deacon S
Sleep; 2010 Nov; 33(11):1562-70. PubMed ID: 21102998
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.
Randall S; Roehrs TA; Roth T
Sleep; 2012 Nov; 35(11):1551-7. PubMed ID: 23115404
[TBL] [Abstract][Full Text] [Related]
14. Measurement of non-restorative sleep in insomnia: A review of the literature.
Vernon MK; Dugar A; Revicki D; Treglia M; Buysse D
Sleep Med Rev; 2010 Jun; 14(3):205-12. PubMed ID: 20018533
[TBL] [Abstract][Full Text] [Related]
15. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
Perlis ML; McCall WV; Krystal AD; Walsh JK
J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
[TBL] [Abstract][Full Text] [Related]
16. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
Maroo N; Hazra A; Das T
Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
[TBL] [Abstract][Full Text] [Related]
18. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
19. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Fava M; Asnis GM; Shrivastava R; Lydiard B; Bastani B; Sheehan D; Roth T
J Clin Psychopharmacol; 2009 Jun; 29(3):222-30. PubMed ID: 19440075
[TBL] [Abstract][Full Text] [Related]
20. MSLT in primary insomnia: stability and relation to nocturnal sleep.
Roehrs TA; Randall S; Harris E; Maan R; Roth T
Sleep; 2011 Dec; 34(12):1647-52. PubMed ID: 22131601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
